Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nanhai Langtai Pharmaceutical is a Chinese biopharmaceutical company specializing in the research, development, and manufacturing of genetic engineering drugs and high-tech biological products. The company is best known for its production of recombinant human epidermal growth factor (rhEGF), which is marketed under the brand name 'Galin' for various wound healing applications, including burns, chronic ulcers, and surgical incisions. Langtai operates a large-scale GMP-certified manufacturing facility in Foshan, Guangdong, and maintains a strong focus on regenerative medicine and tissue repair. Its product portfolio extends to topical solutions and sprays designed to accelerate skin and mucosal recovery.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nanhai Langtai Pharmaceutical.